跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
POTASSIUM ACETATE INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
POTASSIUM ACETATE INJECTION USP
Authorized
STANDARD
POTASSIUM ACETATE INJECTION USP
omega laboratories limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
14b95c2e5bd9679f
Company
omega laboratories limited
Type
Standard
Approval Details
Approval Id
14b95c2e5bd9679f
Drug Approval Canada Name
POTASSIUM ACETATE INJECTION USP
Product Name
POTASSIUM ACETATE INJECTION USP
Status
Marketed
Status Date
2016-07-18
Original Market Date
2016-07-18
Din
02362597
Drug Class
Human
Dosage Form
Liquid
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
40:12.00
Atc Original
B05XA17 POTASSIUM ACETATE
Atc Name
b 05 xa 17
Aig Number
0107304002
Company Name
omega laboratories limited
Company Address
11177 Hamon, Montreal, Quebec, Canada, H3M 3E4
Active Ingredients
POTASSIUM ACETATE
39.2 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
14b95c2e5bd9679f
Type
Standard
Back to Health Canada Approvals